0 — Class I drug recall D-0969-2015
Terminated recall by Hospira Inc., reported 2015-04-29, distributed nationwide. Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at t
| Recall number | D-0969-2015 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2015-01-20 |
| Classified | 2015-04-23 |
| Reported by FDA | 2015-04-29 |
| Terminated | 2017-01-17 |
| Distributed | Nationwide (US) |
| Quantity | 661,128 containers |
| Reason classes | specification failure |
| NDC | 00409-7983-02 |
| Lot numbers | 44-002-JT |
| Expiration dates | 2016-08-01 |
Product
0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02
Reason for recall
Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0969-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.